<DOC>
	<DOCNO>NCT00241670</DOCNO>
	<brief_summary>The aim study `` Fluorescence-guided resection malignant glioma 5-Aminolevulinic acid ( 5-ALA ) vs. conventional resection '' determine accurately contrast agent-accumulating tumour remove primary surgery assess clinical usefulness method .</brief_summary>
	<brief_title>Fluorescence-guided Resection Malignant Gliomas With 5-Aminolevulinic Acid</brief_title>
	<detailed_description>Malignant glioma locally invasive tumor carry dismal prognosis despite combination surgery , radiotherapy chemotherapy . Cytoreductive surgery generally consider beneficial complete resection contrast enhance tumor achieve less 20 % patient , one reason difficulty discern marginal , enhance tumor intraoperatively . Five-aminolevulinic acid ( 5-ALA ) lead accumulation fluorescent porphyrin malignant glioma , phenomenon exploration intraoperative identification resection tumor . This study investigate benefit derive fluorescent-guided resection use 5-ALA surgical radicality , progression-free survival morbidity .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Radiological suspicion unilocular malignant glioma distinct ring garlandshaped contrast agentaccumulating tumour structure core reduce intensity MRI ( central necroses ) significant nonstaining tumour tissue ( exclusion secondary malignant glioma ) . Indication surgical tumour resection . If radical resection plan , location contrast agentaccumulating tumour allow complete resection . First operation tumour , tumourspecific pretreatment Karnofsky least 70 % Patient 's write informed consent Age 1872 year Tumour location midline , basal ganglion , cerebellum brain stem More one contrast agentaccumulating lesion unrelated primary tumour extracerebral metastasis Porphyria , hypersensitivity porphyrin Renal insufficiency : Creatinine &gt; 2.0 mg/dl Hepatic insufficiency : Bilirubin &gt; 3 mg/dl Quick test &lt; 60 % gammaGT &gt; 70 U/I Malignancies basaliomas Existing plan pregnancy lactation , inadequate contraception Simultaneous participation another clinical trial participation another clinical trial 30 day precede randomisation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>